1. Home
  2. BSRR vs GYRE Comparison

BSRR vs GYRE Comparison

Compare BSRR & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$38.54

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

HOLD

Current Price

$6.14

Market Cap

573.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
GYRE
Founded
1977
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
573.4M
IPO Year
2001
2004

Fundamental Metrics

Financial Performance
Metric
BSRR
GYRE
Price
$38.54
$6.14
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$37.00
$17.00
AVG Volume (30 Days)
53.7K
85.3K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
N/A
EPS
0.96
N/A
Revenue
N/A
$275,000.00
Revenue This Year
$11.74
$19.88
Revenue Next Year
$3.63
N/A
P/E Ratio
$39.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.49
$5.44
52 Week High
$39.00
$9.42

Technical Indicators

Market Signals
Indicator
BSRR
GYRE
Relative Strength Index (RSI) 59.34 44.61
Support Level $36.00 N/A
Resistance Level N/A $8.13
Average True Range (ATR) 0.78 0.30
MACD -0.07 -0.01
Stochastic Oscillator 85.20 52.03

Price Performance

Historical Comparison
BSRR
GYRE

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: